This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Wall Street Analysts Believe Afya (AFYA) Could Rally 76%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 76.2% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Is Afya (AFYA) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Afya (AFYA) Q1 Earnings Beat Estimates
by Zacks Equity Research
Afya (AFYA) delivered earnings and revenue surprises of 13.33% and 3.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Nerdy Inc. (NRDY) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Nerdy Inc. (NRDY) delivered earnings and revenue surprises of 8.70% and 0.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
American Public Education (APEI) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
American Public Education (APEI) delivered earnings and revenue surprises of -36.84% and 1.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Sirius XM (SIRI) Earnings and Revenues Improve Y/Y in Q1
by Zacks Equity Research
Sirius XM's (SIRI) first-quarter 2022 results benefit from higher advertising revenues, driven by strong demand for advertising solutions.
VTRU vs. AFYA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
VTRU vs. AFYA: Which Stock Is the Better Value Option?
IMAX's Q1 Earnings Meet Estimates, Revenues Increase Y/Y
by Zacks Equity Research
IMAX's first-quarter 2022 results reflect growth in revenues and global box office, owing to the impressive performance of blockbuster titles.
Company News for Apr 4, 2022
by Zacks Equity Research
Companies In The News Are: JOBS, MAG, NCNO, AFYA.
Afya (AFYA) Misses Q3 Earnings Estimates
by Zacks Equity Research
Afya (AFYA) delivered earnings and revenue surprises of -35.29% and 1%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Afya (AFYA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Afya (AFYA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LINC vs. AFYA: Which Stock Is the Better Value Option?
by Zacks Equity Research
LINC vs. AFYA: Which Stock Is the Better Value Option?
LINC vs. AFYA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LINC vs. AFYA: Which Stock Is the Better Value Option?
New Strong Sell Stocks for September 28th
by Zacks Equity Research
YUM, VC, NKE, AFYA, and FLWS have been added to the Zacks Rank #5 (Strong Sell) List on September 28, 2021.
LRN vs. AFYA: Which Stock Is the Better Value Option?
by Zacks Equity Research
LRN vs. AFYA: Which Stock Is the Better Value Option?
LRN or AFYA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LRN vs. AFYA: Which Stock Is the Better Value Option?
Afya (AFYA) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Afya (AFYA) delivered earnings and revenue surprises of -85.00% and -4.84%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Afya (AFYA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Afya (AFYA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LRN vs. AFYA: Which Stock Is the Better Value Option?
by Zacks Equity Research
LRN vs. AFYA: Which Stock Is the Better Value Option?
LINC vs. AFYA: Which Stock Is the Better Value Option?
by Zacks Equity Research
LINC vs. AFYA: Which Stock Is the Better Value Option?
LRN or AFYA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LRN vs. AFYA: Which Stock Is the Better Value Option?
Strategic Education's (STRA) Capella Boosts FlexPath Portfolio
by Zacks Equity Research
Strategic Education (STRA) is set to include a balanced education format in its FlexPath portfolio at Capella University.
New Strong Sell Stocks for May 27th
by Zacks Equity Research
AFYA, BNL, CLBS, EKSO, and LLY have been added to the Zacks Rank #5 (Strong Sell) List on May 27, 2021
New Strong Sell Stocks for May 18th
by Zacks Equity Research
AFYA, BLU, CHRA, DHX, and EBMT have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2021
American Public (APEI)-Rio Salado Tie Up Over Online Education
by Zacks Equity Research
American Public Education (APEI) collaborates with Rio Salado to promote online education degree with seamless admission and make distance education affordable and accessible.